Marek Honczarenko serves as EVP, Chief Scientific Officer at Keenova Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Marek Honczarenko has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2026 involved receiving (via award) 58,434 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | NONE | $0 | Award | 58,434 | $N/A | Discretionary |
Marek Honczarenko currently holds 58,434 shares of Keenova Therapeutics plc (NONE), valued at approximately $0. This represents their equity stake as EVP, Chief Scientific Officer.
Based on SEC Form 4 filings, Marek Honczarenko has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Marek Honczarenko's most recent insider trade was on Feb 25, 2026, when they sold 58,434 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted